In microorganisms, noise in gene expression gives rise to cell-tocell variability in protein concentrations [1] [2] [3] [4] [5] [6] [7] . In mammalian cells, protein levels also vary [8] [9] [10] and individual cells differ widely in their responsiveness to uniform physiological stimuli [11] [12] [13] [14] [15] . In the case of apoptosis mediated by TRAIL (tumour necrosis factor (TNF)related apoptosis-inducing ligand) it is common for some cells in a clonal population to die while others survive-a striking divergence in cell fate. Among cells that die, the time between TRAIL exposure and caspase activation is highly variable. Here we image sister cells expressing reporters of caspase activation and mitochondrial outer membrane permeabilization after exposure to TRAIL. We show that naturally occurring differences in the levels or states of proteins regulating receptor-mediated apoptosis are the primary causes of cell-to-cell variability in the timing and probability of death in human cell lines. Protein state is transmitted from mother to daughter, giving rise to transient heritability in fate, but protein synthesis promotes rapid divergence so that sister cells soon become no more similar to each other than pairs of cells chosen at random. Our results have implications for understanding 'fractional killing' of tumour cells after exposure to chemotherapy, and for variability in mammalian signal transduction in general.
TRAIL elicits a heterogeneous phenotypic response in both sensitive and relatively resistant cell lines: some cells die within 45 min, others 8-12 h later, and yet others live indefinitely ( Supplementary Fig. 1 ). During the variable delay between TRAIL addition and mitochondrial outer membrane permeabilization (MOMP), upstream initiator caspases are active but downstream effector caspases are not 11, 12 . Possible sources of cell-to-cell variability in response to TRAIL include genetic or epigenetic differences, stochastic fluctuations in biochemical reactions involving low copy number components ('intrinsic noise' 3 ), differences in cell cycle phase, and natural variation in the concentrations of important reactants. To distinguish between these and other possibilities, we used live-cell microscopy to compare the timing and probability of death in sister cells exposed to TRAIL. If phenotypic variability is caused by genetic or epigenetic differences, sister cells should behave identically. In contrast, if stochastic fluctuations in reactions triggered by TRAIL predominate, sister cells should be no more similar to each other than pairs of cells selected at random. The influence of cell cycle state on apoptosis should be readily observable from time-lapse imaging of asynchronous cultures. Furthermore, variability arising from differences in protein levels (or in their activity or modification state) should produce a highly distinctive form of inheritance in which newly born sister cells are very similar, because they inherit similar numbers of abundant factors from their mother 4,7 , but then diverge as new proteins are made and levels drift 10, 16 . With this in mind, we examined apoptosis in HeLa cells and in non-transformed MCF10A mammary epithelial cells in the presence and absence of protein synthesis inhibitors.
Pairs of sister cells expressing a fluorescent reporter of MOMP (mitochondrial intermembrane space reporter protein, IMS-RP 11 ) born during a 20-30 h period were identified by time-lapse microscopy. TRAIL and the protein synthesis inhibitor cycloheximide were then added and imaging continued for another 8 h. The TRAIL-to-MOMP interval (T d ) was calculated for each cell (Fig. 1a ). Among the recently divided sisters (,7 h between division and death), T d was highly correlated (R 2 5 0.93, Fig. 1b ), whereas T d was uncorrelated (R 2 5 0.04) for recently divided cells chosen at random. The time since division ( Fig. 1c ) and the position in the dish (data not shown) did not correlate with T d , ruling out a role for cell cycle state and cellcell interactions under our experimental conditions. However, as the time since division increased, sister-to-sister correlation in T d decayed exponentially with a half-life of ,11 h, so that sisters lost memory of shared ancestry within ,50 h or about two cell generations (R 2 # 0.05, the same as random pairs of cells; Fig. 1d , e). Similar results were obtained with MCF10A cells ( Supplementary Fig. 2 ).
High correlation between recently born sisters shows that the variability in T d arises from differences that exist before TRAIL exposure, and rules out stochastic fluctuations in signalling reactions. Rapid decorrelation also rules out genetic mutation or conventional epigenetic differences (which typically last 10-10 5 cell divisions 17 ). However, transient heritability is precisely what we expected for cell-to-cell differences arising from variations in the concentrations or states of proteins that are partitioned binomially at cell division.
Whereas all TRAIL-treated HeLa cells eventually died in the presence of cycloheximide, in its absence a fraction always survived (presumably owing to induction of survival pathways 18 ). When the fates of sister cells were compared, both lived or both died in most cases (chi-squared test, P 5 7 3 10 219 , Supplementary Fig. 3 ). Variability in T d across the population was large ( Fig. 1g and Supplementary Fig. 4 ), but recently born sisters were nevertheless correlated in T d (R 2 5 0.75, Fig. 1f ). Again, cell cycle phase was not correlated with fate or the time-to-death ( Fig. 1g ). Decorrelation in T d among sisters was an order of magnitude more rapid in the presence of protein synthesis than in its absence (,1.5 h half-life, Fig. 1h , i and Supplementary Fig. 5 ). Thus, the length of time that T d is heritable is very sensitive to rates of protein synthesis, both basal and TRAIL-induced.
We then asked whether the concentrations of proteins regulating TRAIL-induced apoptosis are sufficiently different from cell to cell to account for the variability in T d . Using flow cytometry, we measured the distributions of five apoptotic regulators for which specific antibodies are available. All five proteins were log-normally distributed across the population with coefficients of variation ranging between 0.21 and 0.28 for cells of similar size ( Fig. 2a ), consistent with data on other proteins 10 . To determine the impact of variability in protein levels on variability in time-to-death, we turned to an ordinary differential equation model of TRAIL-induced apoptosis 12 . This model encapsulates the biochemistry of TRAIL-mediated death and recapitulates the dynamics of apoptosis under various conditions of protein depletion or overexpression 12 . When variability in T d arising from variance in protein levels was modelled, a good match was observed to experimental data ( Fig. 2b-d ) indicating that the measured differences in protein levels are sufficient to account for variability in T d .
Next, we investigated which steps in receptor-mediated apoptosis are responsible for variation in time-to-death. To address this question, we grouped reactions into three sets: those occurring before, during, or subsequent to MOMP ( Fig. 3a , blue, grey and orange). Before MOMP, TRAIL binds and oligomerizes DR4/5 receptors, promoting assembly of death-inducing signalling complexes (DISCs) that then activate initiator pro-caspases-8 and -10 (CASP8 and CASP10) 19 . Active CASP8/10 cleave BID to a truncated form (tBID) 20, 21 , which then activates the pore-forming proteins BAX and BAK 22 . CASP8 and CASP10 also process effector pro-caspases-3 and -7 (CASP3 and CASP7), but effector caspase activity is held in check by XIAP until MOMP 19 . MOMP itself involves self-assembly of activated BAX and BAK into transmembrane pores, a process antagonized by anti-apoptotic BCL2 family proteins 22 . When levels of activated tBID, BAX and BAK exceed a threshold set by inhibitory BCL2 proteins, pores form in the mitochondrial outer membrane, allowing cytochrome c and SMAC (also known as DIABLO) to translocate into the cytosol 22 . In post-MOMP reactions, cytosolic SMAC neutralizes XIAP, relieving CASP3 and CASP7 inhibition, and allowing cleavage of effector caspase substrates and consequent cell death 19 . In a parallel route to CASP3 and CASP7 activation, cytosolic cytochrome c promotes apoptosome assembly and caspase-9 activation.
To establish which steps in TRAIL-induced apoptosis have the greatest impact in determining variability in death time, we imaged cells expressing a reporter protein of either initiator or effector caspase activity (IC-RP or EC-RP) 11 in combination with IMS-RP. We found almost all variability in T d to arise during the pre-MOMP interval (Fig. 3b ). The timing of MOMP itself is determined by the rate at which tBID accumulates to a threshold set by the levels of BCL2 family proteins. This rate and threshold can be inferred from the initial rate of IC-RP cleavage (k IC ) and the fraction of IC-RP cleaved (h) at the time of MOMP, respectively. When k IC and h were measured in single TRAIL-treated cells, the timing of MOMP was found to be controlled by a variable rate of approach to a threshold of variable height (Fig. 3c,  d ). However, variation in k IC had a significantly greater role in determining T d than variation in h (R 2 5 0.82 versus R 2 5 0.22; Supplementary Fig. 6 ). e, Correlation between T d and either k IC (left) or h (right), for data in d. f, Relative contributions of variability in k IC (blue) or h (grey) to variability in T d (black; Supplementary  Fig. 7) . g, Representative trajectories of IC-RP cleavage in recently divided sister HeLa cells having similar T d (red) and older sisters with differing T d (black), treated with 50 ng ml 21 TRAIL plus cycloheximide. Fig. 3e, f and Supplementary Fig. 7) . Moreover, k IC was very similar in recently born sister cells with similar T d , but dissimilar in older sisters (Fig. 3g) . We conclude that cell-to-cell variability in k IC -and by implication the rate of conversion of BID to tBID-is the primary determinant of variability in the time-to-death under our experimental conditions. Levels of several proteins set k IC , including DR4/5 receptors, DISC components, CASP8 and BID itself. Modelling suggested that knowing the concentration of any single protein upstream of BID would have minimal value in predicting T d -the impact of variation in all other proteins is too great (Fig. 4a ). Live-cell analysis of FLIP (also known as CFLAR), an important regulator of pro-caspase-8 binding to the DISC, was consistent with this prediction, as was analysis of other single proteins by flow cytometry (Fig. 4b and data not shown) . However, modelling showed that with increasing overproduction of BID, measurement of its levels would be increasingly predictive of T d (Fig. 4c, Supplementary Fig. 8 ). We therefore measured the relationship between dispersion in T d and levels of BID tagged with greenfluorescent-protein (GFP) (Fig. 4d) . A ,50-fold increase in BID caused the variability in T d to fall significantly, concomitant with a decrease in mean time-to-death from ,3 h to ,45 min. Thus, only when overexpressed is the level of one protein predictive of T d ; under normal circumstances, control of T d is multivariate.
Other studies (for example, ref. 23.) address genetic factors determining the average sensitivity of cell lines to TRAIL, whereas this paper examines non-genetic sources of cell-to-cell variability within an individual cell line. We come to three primary conclusions. First, cell-to-cell variation in the timing and probability of death is transiently heritable. Cell cycle state, the number of neighbouring cells, and stochastic fluctuations in TRAIL-induced signalling reactions do not have a crucial involvement under our conditions. Instead, variability in phenotype arises from cell-to-cell differences in protein levels that exist before TRAIL exposure (our experiments do not distinguish between cell-to-cell differences in total concentrations and in posttranslationally modified forms). Second, the rate at which sisters lose memory of a shared past is an order of magnitude faster in the presence of protein translation than in its absence. This further implicates variability in protein levels as the origin of differences in phenotype. Third, knowing the concentration of individual proteins does not allow T d to be predicted, but measuring the rate of a single reaction does (BID to tBID conversion in our experiments). This finding probably holds for other examples of ligand-induced apoptosis; however for intrinsic apoptosis, different proteins will control the rate of approach to MOMP and h may dominate in certain contexts. The fundamental point is that each of these properties is determined by the levels and activities of several proteins. Given the prevalence of multiprotein cascades in signal transduction, multivariate control over cellto-cell variability is likely to be more common than the univariate control observed in other settings 8, 23, 24 .
Heritable, non-genetic determinants of phenotype are often referred to as 'epigenetic' 17 , but the transient heritability we observe here is fundamentally different in origin and duration. Given variability in growth rates and noise in gene expression, genetically identical cells will inevitably contain slightly different concentrations of most proteins. However, differences in protein concentrations do not necessarily affect phenotype, a property often referred to as robustness 25 . For example, the efficiency with which effector caspase substrates are cleaved does not vary much from cell to cell 12 . Given the importance of tight control over apoptosis, cell-to-cell variability in the timing and probability of death seems unlikely to reflect an inability of cells to achieve robust regulation. Instead, by transforming what is a binary decision at the single-cell level into a graded response at the population level, variability probably has an adaptive advantage.
TRAIL is at present undergoing clinical trials as an anti-cancer drug 26 and our findings may have implications for the use of TRAIL and other apoptosis inducers as therapeutics. Many drugs exhibit 'fractional killing', in which each round of therapy kills some but not all of the cells in a tumour 27 . Traditionally, this is thought to reflect differences in genotype, cell cycle state, or the involvement of 
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cancer stem cells, but our data demonstrate that marked variability can also arise from natural differences in protein levels. We propose that the efficiency of TRAIL-mediated killing of cancer cells could be increased by reducing the impact of cell-to-cell variability, perhaps through co-drugging.
METHODS SUMMARY
Live-cell microscopy. Cells expressing IMS-RP and Förster resonance energy transfer (FRET) reporters EC-RP or IC-RP were imaged as described 11 . In Fig. 1 , cells were imaged for 20-30 h to determine the time of division and to identify sister pairs; media containing 50 ng ml 21 TRAIL plus 2.5 mg ml 21 cycloheximide, or 250 ng ml 21 TRAIL alone, was then added. The difference in TRAIL concentrations was designed to generate a similar range in T d with and without cycloheximide ( Supplementary Fig. 4 ). Cells were then imaged for 8 h to determine the time of MOMP, by monitoring cytosolic translocation of IMS-RP. Unless otherwise noted, all treatments included 2.5 mg ml 21 cycloheximide. Data analysis. Correlation coefficients (R 2 ) were obtained by linear regression except where noted. Sister-sister correlation was determined by sorting pairs of cells on T (Div?MOMP) avg (where 'Div' denotes division) and calculating R 2 for the first 40 pairs. R 2 was then recalculated for cells 2-41, 3-42, and so on, and the results were plotted as a function of the average T (Div?MOMP) avg for the 40 cells in question, denoted by ', .'. The results were fit to an exponential decay R 2~1 :2e ({0:063 T(Div?MOMP) avg ) for TRAIL plus cycloheximide, and R 2~2 :3e ({0:47T(Div?MOMP) avg ) for TRAIL alone. Half-lives were calculated as ln(2)/0.063 5 11 h, and ln(2)/0.47 5 1.5 h. Contributions to T d of k IC , h and pre-and post-MOMP intervals were obtained by fixing one parameter at the mean value and allowing the other to vary over the observed range, then meancentring the resulting distributions ( Supplementary Fig. 7 ). Fitted IC-RP trajectories were obtained after subtracting a trajectory for cycloheximide alone (Fig. 3c ) to control for photobleaching ( Supplementary Fig. 6 ).
Modelling. The responses of cell populations were simulated using a trained ordinary differential equation model 12 sampling from log-normally distributed protein concentrations with coefficient of variation (CV) < 0.25 (see Methods). In Fig. 4 , BID-GFP (an experimental observable) was added to log-normally distributed endogenous BID (unobservable); other proteins were sampled from log-normal distributions as before. Simulations were adjusted to match the distribution BID-GFP achieved experimentally.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
